Development and in vitro Evaluation of Voriconazole Nanoparticle Formulation for Mucosal Application

Journal Title: Turkish Journal of Pharmaceutical Sciences - Year 2018, Vol 15, Issue 2

Abstract

Objectives: This study aimed to prepare and evaluate mucoadhesive nanoparticle formulations of voriconazole, an antifungal drug, for mucosal application. It was also aimed to develop and validate a HPLC method of voriconazole. Materials and Methods: In this study, mucoadhesive nanoparticles containing voriconazole were prepared using a coating polymer of chitosan. The obtained nanoparticles were characterized via particle size, polydispersity index, zeta potential measurement, and mucoadhesion studies. Drug loading capacity was tested for determination of the voriconazole amount in the nanoparticles. In vitro drug release was also examined. The HPLC method was validated for linearity, accuracy, precision (repeatability and reproducibility), specificity, stability, limits of detection (LOD), and limit of quantification (LOQ). Results: In vitro characterization results of the mucoadhesive nanoparticle formulation containing voriconazole was found to be appropriate with a small particle size of 217.1±4.2 nm, a narrow polydispersity index of 0.335±0.042, 99.052±0.424% drug loading, and a positive zeta potential value of +26.82±0.4 mV. Accor-ding to a mucoadhesive study, it can be concluded that the nanoparticle was able to interact with mu-cin due to ionic interaction. Also, the turbidity of nanoparticle/mucin dispersion was higher than the turbidity of mucin dispersion itself. Based on the in vitro drug release, no burst effect was observed, indicating that voriconazole was homogeneously dispersed in the nanoparticle dispersion and that no significant amount of drug was adsorbed onto the nanoparticle surface. The release was found to fol-low a non Fickian diffusion mechanism with first order drug release. The proposed HPLC method was simple, highly sensitive with good linearity, accurate, precise, specific, and stable, showing that the method is useful for routine quality control. Conclusion: This study has shown that the mucoadhesive nanoparticle formulation containing voriconazole repor-ted here is a promising candidate for the local treatment of mucosal diseases. The developed HPLC method can be succesfully applied to pharmaceutical preparations containing voriconazole.

Authors and Affiliations

Seda RENÇBER, Sinem Yaprak KARAVANA

Keywords

Related Articles

Quantification of Galantamine in Sternbergia Species by High Performance Liquid Chromatography

Objectives: This study describes the qualitative and quantitative analysis of galantamine in Sternbergia species growing in Turkey. Materials and Methods: Galantamine was isolated from Sternbergia fischeriana bulbs and t...

The Anticancer and Anti-inflammatory Effects of Centaurea solstitialis Extract on Human Cancer Cell Lines

Objectives: Natural products originating from plants have been used for many years in the treatment of various diseases, including cancer. Centaurea solstitialis subsp. solstitialis is used in Turkish folk medicine. This...

Levels of Heavy Metals and Ochratoxin A in Medicinal Plants Commercialized in Turkey

Objectives: The aim of this study was to determine the levels of Pb, Cd, and OTA in frequently used medicinal plants. Materials and Methods: Twenty-one samples of linden, chamomile, and sage were obtained during the spri...

Investigation of the Antioxidant, α-Glucosidase Inhibitory, Anti-inflammatory, and DNA Protective Properties of Vaccinium arctostaphylos L.

Objectives: The scope of this study was to investigate the total phenolic, anthocyanin, and flavonoid contents and the biological properties of ethanol extract (EE), methanol extract (ME), and aqueous extract (AE) from V...

Preparation and Biopharmaceutical Evaluation of Novel Polymeric Nanoparticles Containing Etoposide for Targeting Cancer Cells

Objectives: Polymeric nanoparticles are a promising novel drug delivery system and have advantages in cancer therapy. Etoposide is an anticancer agent that is used in the treatment of a variety of malignancies. The aim o...

Download PDF file
  • EP ID EP382455
  • DOI 10.4274/tjps.54265
  • Views 131
  • Downloads 0

How To Cite

Seda RENÇBER, Sinem Yaprak KARAVANA (2018). Development and in vitro Evaluation of Voriconazole Nanoparticle Formulation for Mucosal Application. Turkish Journal of Pharmaceutical Sciences, 15(2), 142-148. https://europub.co.uk./articles/-A-382455